A patient with lupus nephritis presents with acute worsening renal function, severe proteinuria, and metabolic acidosis. After initial management with high-flow oxygen, diuretics, and intravenous methylprednisolone, the patient's blood pressure remains low, and there is no significant improvement in renal function. Which of the following interventions should the nurse prioritize next to best address the patient's condition?

B) Initiate renal replacement therapy per nephrology recommendations

A) Increase the dose of diuretics to manage fluid overload

B) Initiate renal replacement therapy per nephrology recommendations

C) Administer additional immunosuppressive agents to control lupus activity

D) Provide intravenous albumin to correct hypoalbuminemia

A patient with systemic lupus erythematosus presents with bilateral crackles in the lungs, ascites, elevated creatinine, and significant proteinuria. The interdisciplinary team has initiated high-flow oxygen, diuretics, and intravenous methylprednisolone. What is the PRIORITY nursing intervention to prevent further complications in this patient?

A) Monitor the patient’s fluid balance and adjust diuretic therapy to prevent hypotension.

B) Prepare the patient for immediate renal replacement therapy to address acute kidney injury.

C) Educate the patient and family about lupus management to reduce anxiety and improve compliance.

D) Assess the patient’s neurological status frequently to detect changes related to metabolic acidosis.

A patient with systemic lupus erythematosus is experiencing a severe flare with complications, including hypotension, tachycardia, respiratory distress, and declining renal function. Despite high-flow oxygen therapy, the patient's oxygen saturation remains low. Which of the following nursing interventions is the most critical to prioritize in managing this patient's current condition?

C) Prepare for endotracheal intubation and mechanical ventilation to manage respiratory failure.

A) Increase the dose of methylprednisolone to further suppress autoimmune activity.

B) Initiate continuous renal replacement therapy to address worsening renal function.

C) Prepare for endotracheal intubation and mechanical ventilation to manage respiratory failure.

D) Administer intravenous antibiotics to treat potential underlying infection.

A 32-year-old female patient with systemic lupus erythematosus (SLE) is experiencing a lupus flare complicated by suspected acute lupus pneumonitis, hypotension, and worsening renal function. Despite initial treatment with high-dose methylprednisolone and diuretics, her condition remains critical. As the nurse contributing to the interdisciplinary team, what is the most appropriate nursing intervention to prioritize at this time?

B) Prepare the patient for urgent dialysis to manage her worsening renal failure.

A) Administer prescribed antibiotics immediately to address the potential infection.

B) Prepare the patient for urgent dialysis to manage her worsening renal failure.

C) Increase the oxygen flow rate to improve her oxygen saturation levels.

D) Collaborate with the healthcare provider to discuss additional immunosuppressive therapy.

A patient with systemic lupus erythematosus presents with confusion, altered mental status, and a recent drop in hemoglobin levels. Blood cultures reveal gram-negative bacilli. Which of the following interventions should the nurse prioritize to address the immediate threats to the patient's condition?

A) Initiate broad-spectrum antibiotics based on sensitivity profile.

B) Prepare the patient for plasmapheresis to control lupus activity.

C) Administer a blood transfusion to address the drop in hemoglobin.

D) Monitor neurological status closely and prepare for potential respiratory support.

A patient with systemic lupus erythematosus (SLE) presents with neurological deterioration. Blood cultures are positive for gram-negative bacilli, and the patient is anemic with a hemoglobin level of 7.8 g/dL. Considering the need to balance immunosuppression and infection control, which intervention should the nurse anticipate as the priority in the patient's plan of care?

B) Administer broad-spectrum antibiotics immediately to address bacteremia.

A) Initiate high-dose corticosteroids to rapidly control lupus cerebritis.

B) Administer broad-spectrum antibiotics immediately to address bacteremia.

C) Transfuse packed red blood cells to address the low hemoglobin level.

D) Start plasmapheresis to manage severe lupus activity.

A patient with lupus cerebritis and gram-negative bacteremia is admitted to the ICU. She presents with hypotension, tachycardia, fever, and signs of respiratory distress. After initiating plasmapheresis and ceftriaxone therapy, the patient's renal function shows deterioration. Which nursing intervention is the highest priority at this time?

A) Administer intravenous fluids to manage hypotension and prevent septic shock.

B) Prepare the patient for immediate endotracheal intubation due to respiratory distress.

C) Monitor neurological status closely to assess for progression of lupus cerebritis.

D) Initiate continuous renal replacement therapy to support renal function and manage fluid overload.

A patient with lupus cerebritis and gram-negative bacteremia is being managed in the intensive care unit. Despite treatment with ceftriaxone, the patient's vital signs show persistent hypotension, tachycardia, and signs of potential septic shock. Which intervention should the nurse prioritize to stabilize the patient's hemodynamic status?

B) Administer vasopressors to address persistent hypotension unresponsive to fluids.

A) Increase the rate of intravenous fluid administration to manage hypotension.

B) Administer vasopressors to address persistent hypotension unresponsive to fluids.

C) Initiate high-dose corticosteroids to aggressively treat lupus cerebritis.

D) Prepare for emergency plasmapheresis to rapidly reduce immune complexes.

A patient in the ICU with systemic lupus erythematosus (SLE) is experiencing respiratory acidosis, hypoxemia, hemodynamic instability, and coagulopathy indicating possible disseminated intravascular coagulation (DIC). Given the current clinical scenario, what is the nurse's priority action to support the healthcare team in stabilizing the patient's condition?

C) Optimize mechanical ventilation settings to improve oxygenation and ventilation.

A) Administer high-dose corticosteroids to manage lupus cerebritis.

B) Prepare for the administration of intravenous immunoglobulin (IVIG) as adjunctive therapy.

C) Optimize mechanical ventilation settings to improve oxygenation and ventilation.

D) Increase the dose of vasopressor support to maintain adequate blood pressure.

A patient in the ICU with lupus cerebritis is experiencing respiratory acidosis, hypoxemia, and hemodynamic instability despite aggressive management. As part of the interdisciplinary team, what is the most appropriate nursing action to prioritize in the immediate care of this patient?

B) Advocate for the initiation of mechanical ventilation settings to increase pO2 levels.

A) Increase the dose of norepinephrine to improve blood pressure stability.

B) Advocate for the initiation of mechanical ventilation settings to increase pO2 levels.

C) Suggest an immediate re-evaluation of fluid resuscitation strategy to address renal function.

D) Recommend continuous monitoring and titration of immunosuppressive therapy to balance sepsis management.

SLE in acute setting - Nursing Case Study

Pathophysiology

• Primary mechanism: Autoantibody production against nuclear components leads to immune complex deposition, primarily affecting kidneys (lupus nephritis), skin, and joints. This triggers inflammation and tissue damage via complement activation, critical in acute flares.

• Secondary mechanism: Dysregulated apoptosis results in excessive nuclear antigen exposure and perpetuates autoantibody production, intensifying systemic inflammation. This can lead to widespread tissue injury and organ dysfunction.

• Key complication: Rapidly progressive glomerulonephritis can occur, leading to acute renal failure. This necessitates prompt intervention to prevent irreversible kidney damage and manage systemic complications.

Patient Profile

Demographics:

35-year-old female, nurse

History:

• Key past medical history: Diagnosed with Systemic Lupus Erythematosus (SLE) 10 years ago, recurrent lupus nephritis, hypertension

• Current medications: Hydroxychloroquine, Prednisone, Mycophenolate mofetil, Lisinopril

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe joint pain and shortness of breath

• Key symptoms: High fever, acute chest pain, persistent fatigue, facial rash, swelling in legs and abdomen

• Vital signs: Blood pressure 90/60 mmHg, heart rate 125 bpm, respiratory rate 28 breaths/min, temperature 39.5°C, oxygen saturation 85% on room air

Section 1

As the medical team initiates the initial assessment, the patient's condition appears increasingly precarious. A physical examination reveals pronounced bilateral crackles upon auscultation of the lungs, suggesting pulmonary involvement, likely due to lupus-related pleuritis or possible pulmonary edema secondary to nephrotic syndrome. The patient's abdomen is distended, with shifting dullness indicative of ascites, potentially reflecting severe hypoalbuminemia from nephrotic-range proteinuria. Concurrently, significant peripheral edema in the lower extremities is noted, further supporting a systemic fluid imbalance possibly exacerbated by compromised renal function.

Laboratory results return rapidly, shedding light on the extent of the systemic impact. Blood tests reveal severely elevated creatinine levels at 4.5 mg/dL, confirming acute deterioration in renal function. Complement levels, particularly C3 and C4, are markedly low, consistent with active lupus nephritis. Urinalysis shows significant proteinuria exceeding 3.5 grams per day, along with hematuria, reinforcing the diagnosis of rapidly progressive glomerulonephritis. Arterial blood gases indicate a metabolic acidosis with a pH of 7.30, HCO3 of 18 mEq/L, and PaCO2 of 30 mmHg, further hinting at renal impairment and respiratory compensation due to tachypnea.

In response to the critical findings, the interdisciplinary team swiftly mobilizes to address the multifaceted crisis. High-flow oxygen is administered to ameliorate hypoxia, while diuretics are cautiously introduced to manage fluid overload, considering the delicate balance needed given her hypotension. Immunosuppressive therapy is escalated with intravenous methylprednisolone to urgently quell the autoimmune onslaught. A nephrology consult is expedited to evaluate the need for renal replacement therapy. The immediate focus is on stabilizing the patient, preventing further organ damage, and meticulously adjusting treatment to her rapidly evolving clinical picture. This juncture necessitates vigilant monitoring and dynamic clinical decision-making to navigate the complexities of her acute lupus flare.

Section 2

As the team continues to monitor the patient closely, her vital signs reveal concerning trends. Blood pressure remains low at 85/50 mmHg, with a heart rate of 115 beats per minute, indicating persistent hypotension and compensatory tachycardia. Despite high-flow oxygen therapy, her oxygen saturation fluctuates between 88% and 90%, prompting considerations of progressive pulmonary involvement. Respiratory rate remains elevated at 28 breaths per minute, reflecting ongoing respiratory distress. Temperature spikes to 38.3°C, suggesting a potential infectious process superimposed on her lupus flare.

In light of these developments, additional diagnostic tests are ordered. A chest X-ray demonstrates bilateral infiltrates, raising suspicion for acute lupus pneumonitis or secondary infection such as pneumonia. Blood cultures are obtained to rule out sepsis, given her febrile state and immunosuppressed condition. The echocardiogram reveals mild pericardial effusion, a common complication in systemic lupus erythematosus, further complicating her hemodynamic status.

The response to interventions thus far is mixed. Diuretics have provided some relief from peripheral edema, but the patient's renal function continues to decline, with repeat creatinine levels rising to 5.2 mg/dL. This prompts urgent discussion regarding initiation of renal replacement therapy. The methylprednisolone has not yet fully curbed the autoimmune activity, necessitating consideration of additional immunosuppressive agents or biologics. The healthcare team is faced with the challenge of balancing aggressive treatment of her lupus flare while addressing the secondary complications arising from her critical state. This precarious balance demands constant reassessment and adaptation of the treatment plan, as the patient teeters on the edge of multiple organ dysfunction.

Section 3

As the healthcare team continues to manage the patient's complex condition, a new complication emerges. The patient's neurological status begins to deteriorate, with episodes of confusion and altered mental status observed during rounds. A rapid neurological assessment reveals decreased responsiveness and disorientation to time and place. This change prompts immediate concerns regarding central nervous system involvement, a known but severe complication of systemic lupus erythematosus. The team decides to perform a lumbar puncture to evaluate for lupus cerebritis or infectious meningitis, given the patient's immunocompromised state and recent febrile episodes.

Simultaneously, additional diagnostic results return. Blood cultures are positive for gram-negative bacilli, confirming bacteremia and necessitating the initiation of broad-spectrum antibiotics tailored to the organism's sensitivity profile. This finding underscores the precarious balance between immunosuppression and infection risk. Her laboratory results also reveal a marked drop in hemoglobin to 7.8 g/dL, suggesting possible hemolytic anemia, a complication that can be exacerbated by both lupus activity and infection. The healthcare team is now tasked with adjusting the treatment plan to address these multifaceted issues, weighing the risks and benefits of intensified immunosuppression against the need for aggressive infection control.

Given the new developments, the patient's status is reassessed, and the decision is made to escalate care to the intensive care unit for closer monitoring and more intensive support. The potential for multiple organ dysfunction looms as renal function remains compromised and central nervous system involvement further complicates her clinical picture. The team faces critical decisions regarding the initiation of plasmapheresis to address severe lupus activity, while carefully monitoring for further neurological decline and potential respiratory failure. This complex interplay of factors requires advanced clinical judgment and a collaborative, interdisciplinary approach to optimize patient outcomes in the face of evolving challenges.

Section 4

As the patient is transferred to the intensive care unit, the initial assessment reveals further deterioration in her neurological status. She is now exhibiting signs of decreased consciousness, with a Glasgow Coma Scale score of 10. Her vital signs show tachycardia with a heart rate of 112 bpm, hypotension with a blood pressure of 88/52 mmHg, and a fever of 39.2°C (102.6°F). Respiratory examination reveals shallow breathing with a rate of 26 breaths per minute and an oxygen saturation of 90% on room air, prompting the initiation of supplemental oxygen therapy. The patient's skin is cool and clammy, and she exhibits generalized pallor and mild jaundice, consistent with ongoing hemolysis.

New diagnostic results provide crucial insights. The lumbar puncture reveals clear cerebrospinal fluid with an elevated protein level of 150 mg/dL and a white cell count of 80 cells/mm³, predominantly lymphocytes. These findings are suggestive of lupus cerebritis rather than infectious meningitis, necessitating a reevaluation of her immunosuppressive regimen. The gram-negative bacilli identified in blood cultures are sensitive to ceftriaxone, which has been initiated, yet her clinical instability raises concerns about sepsis and potential septic shock, especially given her hypotension and tachycardia.

In response to these critical findings, the healthcare team decides to initiate plasmapheresis to aggressively manage the lupus cerebritis while concurrently optimizing antibiotic therapy to address the bacteremia. The interdisciplinary team, including critical care, rheumatology, and infectious disease specialists, collaborates to closely monitor renal function, which shows a creatinine level of 2.3 mg/dL, indicating worsening renal impairment. Continuous renal replacement therapy is considered to manage potential fluid overload and support renal function. As the patient's condition remains precarious, the team remains vigilant for signs of respiratory failure, prepared to escalate to mechanical ventilation if necessary. This high-stakes scenario demands constant reassessment and adaptation of the treatment plan to navigate the intricate balance between immunosuppression and infection control while ensuring adequate support for all organ systems.

Section 5

As the patient remains under close observation in the intensive care unit, a sudden change in her status prompts immediate attention. Over the course of a few hours, her respiratory pattern becomes irregular, with periods of apnea followed by gasping breaths. The supplemental oxygen therapy is no longer sufficient, as her oxygen saturation drops to 84% despite being on a non-rebreather mask. The team decides to proceed with intubation and mechanical ventilation to stabilize her respiratory function. Arterial blood gas analysis post-intubation reveals a pH of 7.28, a pCO2 of 55 mmHg, and a pO2 of 60 mmHg, indicating respiratory acidosis with hypoxemia, further complicating her clinical picture.

Concurrently, the patient's hemodynamic status continues to be unstable. Despite aggressive fluid resuscitation and vasopressor support with norepinephrine, her blood pressure remains low, with readings fluctuating around 85/50 mmHg. Laboratory tests reveal worsening coagulopathy, with a platelet count dropping to 48,000/µL and an international normalized ratio (INR) of 2.0, raising concerns about disseminated intravascular coagulation (DIC). Furthermore, her renal function deteriorates, with creatinine levels escalating to 3.1 mg/dL, prompting the initiation of continuous renal replacement therapy to manage her fluid status and support her kidneys.

These developments necessitate a reassessment of the treatment strategy. The healthcare team deliberates the risks and benefits of continuing high-dose corticosteroids for lupus cerebritis amidst the ongoing sepsis. The interdisciplinary team explores the addition of intravenous immunoglobulin (IVIG) as an adjunctive therapy to modulate her immune response without exacerbating her infection risk. Balancing immunosuppression and infection control becomes increasingly complex, demanding precise clinical judgment as the team strives to stabilize the patient and prevent further organ dysfunction. The situation underscores the critical need for vigilant monitoring and adaptability in the management plan to navigate this highly intricate clinical scenario.